China’s Food and Drug Administration (CFDA) has announced the second batch of infant nutrition companies and products that have been approved under its new registration programme.
China’s Food and Drug Administration (CFDA) has announced the first wave of infant nutrition companies and products that have passed its new registration programme, and are now free to trade in the country from January 1, 2018.
Changes to the gut’s microbial diversity, as a result of a modern lifestyle, may be responsible for a rise in chronic diseases, such as asthma, obesity and inflammatory bowel disease, an expert suggests.
China’s Food and Drug Administration has announced it tested the ingredients of 217 batches of infant formula in June, and that no unqualified samples were found.
Reports that some infant formula products on sale in Australia and New Zealand contain potentially 'dangerous' nanoscale particles have been dismissed by regulators and scientists — with one branding it blatant 'scaremongering'.
Infant formula milk manufacturers claim stricter regulations planned by the Singapore government could lead to consumers having limited access to important nutritional information.
The Singapore government has established a task force to counter the country’s increasing formula milk prices, with health and nutrition claims set to be severely restricted.
Hong Kong-listed infant nutrition company Ausnutria's total revenues have grown by almost one-third to RMB751.3 million during the first quarter of 2017.
Altering the droplet size and coating of fats used in infant milk could modify postprandial responses in men, according to new research deemed 'very important' by the authors.
Revenues at Hong Kong-listed infant nutrition company AusNutria soared by 30.3% to RMB2,740.3 million (US$396 million) for 2016, despite intense market competition, most notably due to new regulations in China.
Aptamil, one of Danone’s infant formula brands sold in 45 countries, has been launched in India, with the company saying it plans to produce local supply at the company’s Lalru, Punjab facility.
Replacing CEO Laura McBain hasn’t seen the end of financial turmoil at Australian infant formula manufacturer Bellamy’s with shares continuing to slide amid gloomy forecasts from analysts.
With more than 100 infant milk powder manufacturers established and thousands of product lines launched in the last 30 years, overcrowding in the segment appears to have hit Chinese businesses hard.
Australian infant formula firm Bellamy’s is facing further turmoil after a major shareholder demanded the removal of four of the company’s board directors.
Food and nutrition firms in APAC have to contend with a diverse and at times contradictory regulatory landscape across the region, with rules and laws being amended or introduced all the time. And 2016 was no exception.
Danone’s Milupa Nutricia has signed a deal with online retailer windeln.de to better distribute its Aptamil infant formula brand in China as it seeks to thwart the booming grey market.
New Zealand’s a2 Milk Company has signalled its intention to branch out from infant formula into a broader range of dairy-based nutritional products – with the burgeoning China market very much in its sights.
Health and medical experts in New Zealand have called for a ban on soy-based infant formula after a recent mouse study suggested soy damages the reproductive tract and immune system.